Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Bart Jacobs
Profile
Projects
Publications
Activities
Awards & Distinctions
3
Results
2023
Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant
Gwenn Waerlop
Yorick Janssens
Bart Jacobs
Franziska Jarczowski
André Diessner
Geert Leroux-Roels
Victor Klimyuk
Isabel Leroux-Roels
Frank Thieme
A1
Journal Article
in
FRONTIERS IN IMMUNOLOGY
2023
Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate : a randomised, double-blind, placebo-controlled, phase 2a trial
Isabel Leroux-Roels
Paul Willems
Gwenn Waerlop
Yorick Janssens
Jessika Tourneur
FIEN DE BOEVER
Jacques Bruhwyler
Azhar Alhatemi
Bart Jacobs
Florence Nicolas
et al.
A1
Journal Article
in
LANCET INFECTIOUS DISEASES
2023
2022
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine
Isabel Leroux-Roels
Cathy Maes
Jasper Joye
Bart Jacobs
Franziska Jarczowski
André Diessner
Yorick Janssens
Gwenn Waerlop
Kirsi Tamminen
Suvi Heinimäki
et al.
A1
Journal Article
in
FRONTIERS IN IMMUNOLOGY
2022